These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8835694)

  • 21. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
    J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating depressed primary care patients improves their physical, mental, and social functioning.
    Coulehan JL; Schulberg HC; Block MR; Madonia MJ; Rodriguez E
    Arch Intern Med; 1997 May; 157(10):1113-20. PubMed ID: 9164377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ego Impairment Index as a predictor of outcome in melancholic depressed patients treated with tricyclic antidepressants.
    Perry W; Viglione DJ
    J Pers Assess; 1991 Jun; 56(3):487-501. PubMed ID: 1865307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of continuation treatment on residual symptoms in late-life depression: how well is "well"?
    Opdyke KS; Reynolds CF; Frank E; Begley AE; Buysse DJ; Dew MA; Mulsant BH; Shear MK; Mazumdar S; Kupfer DJ
    Depress Anxiety; 1996-1997; 4(6):312-9. PubMed ID: 9166659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of the Affective Self Rating Scale for manic, depressive, and mixed affective states.
    Adler M; Liberg B; Andersson S; Isacsson G; Hetta J
    Nord J Psychiatry; 2008; 62(2):130-5. PubMed ID: 18569776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders.
    Lutz W; Stulz N; Köck K
    J Affect Disord; 2009 Nov; 118(1-3):60-8. PubMed ID: 19217669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor activity and severity of depression in hospitalized prepubertal children.
    Aronen ET; Teicher MH; Geenens D; Curtin S; Glod CA; Pahlavan K
    J Am Acad Child Adolesc Psychiatry; 1996 Jun; 35(6):752-63. PubMed ID: 8682756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance between clinical and self-report depression scales during the acute phase and after treatment.
    Senra C; Polaino A
    J Affect Disord; 1993 Jan; 27(1):13-9. PubMed ID: 8432955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
    Inoue T; Tsuchiya K; Miura J; Sakakibara S; Denda K; Kasahara T; Koyama T
    Biol Psychiatry; 1996 Jul; 40(2):151-3. PubMed ID: 8793048
    [No Abstract]   [Full Text] [Related]  

  • 34. [The Carroll Scale for Depression--the German version and validation].
    Merten T
    Psychiatr Neurol Med Psychol (Leipz); 1990 Jun; 42(6):340-7. PubMed ID: 2402541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psychopathologic prediction of ambulatory doxepin response. A replication trial].
    Philipp M; Maier W
    Nervenarzt; 1988 Aug; 59(8):482-7. PubMed ID: 3173595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships among measures of treatment outcome in depressed patients.
    Mulder RT; Joyce PR; Frampton C
    J Affect Disord; 2003 Sep; 76(1-3):127-35. PubMed ID: 12943942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of variability in residual symptoms with recurrence of major depressive disorder during maintenance treatment.
    Karp JF; Buysse DJ; Houck PR; Cherry C; Kupfer DJ; Frank E
    Am J Psychiatry; 2004 Oct; 161(10):1877-84. PubMed ID: 15465986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring response in treatment of depression.
    Blum MH
    J Clin Psychiatry; 1994 Feb; 55(2):77. PubMed ID: 8077158
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prospective study using a modified Montgomery-Asberg Depression Scale].
    Möller HJ; Schnitker J
    Nervenarzt; 2007 Jun; 78(6):685-90. PubMed ID: 17492265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.
    Carmody TJ; Rush AJ; Bernstein I; Warden D; Brannan S; Burnham D; Woo A; Trivedi MH
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):601-11. PubMed ID: 16769204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.